Avanos Medical (AVNS) Change in Receivables (2013 - 2026)
Avanos Medical (AVNS) reported Change in Receivables of $300000.0 for Q1 2026, up 101.2% on a YoY basis from $149108.9 in Q1 2025, and up 103.7% sequentially from -$8.1 million in Q4 2025.
Avanos Medical (AVNS) Change in Receivables (2013 - 2026) Analysis & Trends
Avanos Medical (AVNS) has 14 years of Change in Receivables data on file, last reported at $300000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 101.2% year-over-year to $300000.0; the trailing twelve-month figure through Mar 2026 stood at -$5.5 million (up 46.6% YoY), and the FY2025 full-year result was -$30.9 million, down 568.18% from the prior year.
- Change in Receivables advanced to $300000.0 in Q1 2026, from -$8.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $18.7 million in Q4 2022 to a low of -$26.2 million in Q1 2023.
- A 5-year average of -$2.3 million and a median of -$700000.0 in 2025 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables soared 6133.33% in 2022 and tumbled 2600.0% in 2025, its largest moves.
- Tracing AVNS's Change in Receivables over 5 years: stood at $18.7 million in 2022, then slumped by 148.13% to -$9.0 million in 2023, then soared by 96.67% to -$300000.0 in 2024, then plunged by 2600.0% to -$8.1 million in 2025, then jumped by 103.7% to $300000.0 in 2026.
- Business Quant data shows AVNS's Change in Receivables at $300000.0 in Q1 2026, -$8.1 million in Q4 2025, and -$700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | -8.10 Mn |
| Dec 31, 2025 | -8.10 Mn |
| Sep 30, 2025 | -700,000.00 |
| Sep 30, 2025 | -700,000.00 |
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | -25.10 Mn |
| Mar 31, 2025 | -25.10 Mn |
| Dec 31, 2024 | -300,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | 7.70 Mn |
| Sep 30, 2024 | 7.70 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Mar 31, 2024 | -8.20 Mn |
| Mar 31, 2024 | -8.20 Mn |
| Dec 31, 2023 | -9.00 Mn |
| Dec 31, 2023 | -9.00 Mn |